Dow Up0.59% Nasdaq Up0.75%

Albany Molecular Research Inc. (AMRI)

-NasdaqGS
21.96 Up 0.24(1.10%) 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 68,179   59,321   67,122   60,755  
Cost of Revenue45,038  41,610  47,103  44,548  
Gross Profit 23,141   17,711   20,019   16,207  
Operating Expenses
Research Development128  79  44  94  
Selling General and Administrative13,171  9,937  11,517  9,820  
Non Recurring4,760  230  1,492  276  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 5,082   7,465   6,966   6,017  
Income from Continuing Operations
Total Other Income/Expenses Net(192)(40)(88)(123)
Earnings Before Interest And Taxes4,890  7,425  6,878  5,894  
Interest Expense3,065  2,616  1,011  (140)
Income Before Tax1,825  4,809  5,867  6,034  
Income Tax Expense(1,899)1,309  1,375  1,648  
Minority Interest -   -   -   -  
Net Income From Continuing Ops3,724  3,500  4,492  4,386  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 3,724   3,500   4,492   4,386  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 3,724   3,500   4,492   4,386  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.